Lexagene Holdings (Lexagene Holdings) Beneish M-Score : 0.00 (As of May. 29, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Lexagene Holdings's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of Lexagene Holdings was 0.00. The lowest was 0.00. And the median was 0.00.

Lexagene Holdings Beneish M-Score Historical Data

The historical data trend for Lexagene Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Beneish M-Score Chart

Lexagene Holdings Annual Data

Trend

Mar13

Mar14

Mar15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Beneish M-Score

Get a 7-Day Free Trial

-3.27

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Beneish M-Score	Get a 7-Day Free Trial															-	-3.27	-3.11	-4.68	-4.42

Competitive Comparison of Lexagene Holdings's Beneish M-Score

For the Medical Devices subindustry, Lexagene Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lexagene Holdings's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Beneish M-Score falls into.

Lexagene Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Lexagene Holdings for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 1.8667

0.528 * 0.4227

0.404 * 0.3758

0.892 * 0.7143

0.115 * 0.791

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 0.9904

4.679 * -0.361032

0.327 * 2.12

-4.57

This Year (Nov22) TTM:

Last Year (Nov21) TTM:

Total Receivables was $0.05 Mil.
Revenue was 0.043 + 0.061 + 0.015 + -0.014 = $0.11 Mil.
Gross Profit was -0.147 + -0.187 + -0.141 + -0.179 = $-0.65 Mil.
Total Current Assets was $2.30 Mil.
Total Assets was $3.49 Mil.
Property, Plant and Equipment(Net PPE) was $1.16 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.52 Mil.
Selling, General, & Admin. Expense(SGA) was $2.66 Mil.
Total Current Liabilities was $1.66 Mil.
Long-Term Debt & Capital Lease Obligation was $0.56 Mil.
Net Income was -1.678 + -2.077 + -2.111 + -2.309 = $-8.18 Mil.
Non Operating Income was 0 + 0 + 0 + -0.014 = $-0.01 Mil.
Cash Flow from Operations was -1.63 + -1.637 + -1.797 + -1.837 = $-6.90 Mil.

Total Receivables was $0.04 Mil.
Revenue was 0.048 + 0.041 + 0 + 0.058 = $0.15 Mil.
Gross Profit was -0.1 + -0.091 + -0.095 + -0.101 = $-0.39 Mil.
Total Current Assets was $3.66 Mil.
Total Assets was $5.36 Mil.
Property, Plant and Equipment(Net PPE) was $1.57 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.51 Mil.
Selling, General, & Admin. Expense(SGA) was $3.75 Mil.
Total Current Liabilities was $0.68 Mil.
Long-Term Debt & Capital Lease Obligation was $0.93 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(0.052 / 0.105)	/	(0.039 / 0.147)
	=	0.495238	/	0.265306
	=	1.8667

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(-0.387 / 0.147)	/	(-0.654 / 0.105)
	=	-2.632653	/	-6.228571
	=	0.4227

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (2.296 + 1.16) / 3.49)	/	(1 - (3.658 + 1.565) / 5.362)
	=	0.009742	/	0.025923
	=	0.3758

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	0.105	/	0.147
	=	0.7143

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0.511 / (0.511 + 1.565))	/	(0.524 / (0.524 + 1.16))
	=	0.246146	/	0.311164
	=	0.791

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(2.655 / 0.105)	/	(3.753 / 0.147)
	=	25.285714	/	25.530612
	=	0.9904

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0.561 + 1.655) / 3.49)	/	((0.926 + 0.68) / 5.362)
	=	0.634957	/	0.299515
	=	2.12

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-8.175 - -0.014	-	-6.901)	/	3.49
	=	-0.361032

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Lexagene Holdings has a M-score of -4.57 suggests that the company is unlikely to be a manipulator.

Lexagene Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (Lexagene Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » Beneish M-Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915

Website

https://www.lexagene.com

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.